BPC-157 Capsules — Oral Gastric-Derived Peptide

The same 15-amino-acid BPC-157 peptide, compounded into an oral capsule (500 mcg per capsule) by a state-licensed U.S. pharmacy. You take it by mouth — there is no mixing, no syringe and no injection.

Most peptides are broken apart by stomach acid and digestive enzymes, which is why most are injected. BPC-157 is unusual: it comes from a protein found in gastric juice, and laboratory work reports that it stays intact in stomach acid. That stability has been shown in the lab — oral BPC-157 has been studied almost entirely in animals, and it has not been compared with the injectable in people.

No. Compounded BPC-157 is not an FDA-approved drug product. In October 2026 HHS announced an interim policy under which FDA does not intend to take enforcement action against pharmacies compounding single-ingredient BPC-157, TB-500 or MOTS-C under specific conditions — that is not FDA approval. Yours is compounded by a state-licensed U.S. pharmacy for your individual prescription, and only after a licensed provider reviews your health history and decides it is appropriate for you.

BPC-157 Capsules (500 mcg per capsule) is sold as a 1-month plan (30 capsules, $229 one-time or $194.65 with auto-refill), a 2-month plan (60 capsules, $339 one-time or $288.15 with auto-refill) or a 3-month plan (90 capsules, $449 one-time or $381.65 with auto-refill) — the 2-month plan saves $119 vs. two 1-month orders and the 3-month plan saves $238 vs. three 1-month orders. That is what ships and what you pay — your provider sets your dose when they write the prescription, so how long a plan lasts depends on the dose they prescribe. Auto-refill is optional, takes 15% off any plan and cancels anytime; free shipping is included on every plan.

Both are compounded from the same 15-amino-acid sequence. The capsule is taken by mouth with nothing to inject; the injectable is a subcutaneous injection that ships with syringes and alcohol prep pads. The two forms have not been compared head to head in people, so there is no evidence that one works better than the other. Whether either fits your health history — and which — is your provider's decision.

We don't promise specific results or a timeline. Compounded BPC-157 is not FDA-approved, most published research on it is in animals and cells, and how people respond varies. Your licensed provider talks through realistic expectations for your health history and sets your dose and schedule when they write your prescription.

Because human research on BPC-157 is limited, its side-effect profile in people is not well characterized. With the oral form, reported reactions are usually mild and digestive — nausea, stomach upset or a change in bowel habits — along with headache or dizziness. An allergic reaction is possible with any medication. Tell your provider about everything you take, and message your care team if anything doesn't feel right.

Because laboratory research links BPC-157 to blood-vessel-formation signaling, it is generally not prescribed for anyone with active cancer or a history of cancer. It is also not used during pregnancy or breastfeeding, or by anyone allergic to any component of the capsule. Your provider reviews your full health history during intake and won't prescribe it if it isn't appropriate for you.

They ship free from a licensed U.S. pharmacy, with 2-day discreet delivery. The capsules come in a sealed bottle — there are no syringes, prep pads or injection supplies to manage. Store them the way your pharmacy label directs.